Merck & Co., Inc: Stock Set to Gain as Drug Sales Improve

  • Derek Hansen
  • 1 month ago
  • 0
Merck & Co., Inc., a global healthcare company, announced its fourth quarter 2017 revenue of $10.4bn (an increase of 3% from Q4 2016 revenue of $10.1bn) and full-year revenue of $40.1bn (an increase of 0.8% from the 2016 year revenues of $39.8bn). Its Human health business grew by 3% while Animal Health business grew by […]

Investor Education: How to Trade Biotech Stocks

  • Richard Cox
  • 7 Months ago
  • 0
Investor Education: How to Trade Biotech Stocks The biotechnology space is one of the most modern and exciting sectors of the market.  These are the companies that push humanity forward in the extinction of disease and treatments for illusive illnesses.  For investors, the stocks that are associated with these companies can provide some highly lucrative […]